EUVIMEDEUVIMED entdecken
Multizentrische Studie

Distribution, severity, and management of joint pain in patients with acromegaly

Nikolaos Kyriakakis, Megan Heague iD, Sophie Hebden, Nawaz Safdar, David S McLaren iD, Alberto S Tresoldi, Kirstie Lithgow, Sandrine Urwyler, Chetna Varsani, Shahzad Akbar, Katie McLoughlin, Katarzyna Adeniji und 7 weitere

European Journal of Endocrinology · 04.03.2026 · 194 (3) · 413-421

DOI: 10.1093/ejendo/lvag045 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Endocrinology, online erschienen am 05.03.2026. Verfasst von Nikolaos Kyriakakis und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, United Kingdom. Hauptthemen laut MEDLINE: Acromegaly, Arthralgia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Pfizer UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The acromegaly-associated arthropathy (AcAA) is a determinant of long-term impaired quality of life. There are limited data assessing the impact of arthropathy, determinants of future arthropathy, and current management.

Design

Multicentre cross-sectional questionnaire study of arthropathy in 6 UK endocrine centres.

Methods

The study incorporated questionnaires relating to distribution of arthralgia, severity of pain, and clinical management of AcAA. Demographics and laboratory data were extracted from medical records.

Results

We enrolled 411 patients (210 female, median 60, IQR 50-69 years) and median 13 (IQR 6-22) years since diagnosis. Joint pain was reported by 82.5%, with 43.3% and 13.1% experiencing moderate and severe joint pain respectively. The most frequently affected joints were knees (54.7%), lower back (47.7%), hips (38.9%), and shoulders (38.6%). Two hundred and forty-seven (60.1%) were taking at least one analgesic, 137 (33.3%) at least 2 classes of analgesics. One hundred and nine (26.5%) patients had at least one joint injection (median 2, 1-20). Seventy (17.0%) had at least one joint prosthesis (median 2, 1-6), at median age 59 (32-82) years. A similar percentage (17.0%) had other forms of joint surgery. Patients aged ≤50 years experienced less pain, required fewer joint injections and less joint surgery, but a similar prevalence of analgesic use, with 36.4% and 10.3% reporting moderate or severe pain.

Conclusion

This study therefore highlights the burden of arthropathy in patients with acromegaly, estimates the need for therapeutic interventions, and the impact on health services.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcromegalyArthralgiaHumansFemaleMiddle AgedCross-Sectional StudiesMaleAgedSeverity of Illness IndexSurveys and QuestionnairesAnalgesicsAdultQuality of LifePain Measurement

Stichwörter der Autor:innen

acromegalyanalgesiaarthropathyjointpain

Substanzen

Analgesics

Autor:innen und Institutionen

  • Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, United Kingdom.
  • Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds LS2 9JT, United Kingdom.
  • Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham B15 2TT, United Kingdom.
  • Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham B15 2TT, United Kingdom.
  • Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, United Kingdom.
  • Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Trust, EC1A 7BE, London, United Kingdom.

ORCID-Profile: Megan Heague, David S McLaren, Thozhukat Sathyapalan, Niki Karavitaki, Robert D Murray

Förderung

  • Pfizer UK

Zitieren

APA

Kyriakakis, N., Heague, M., Hebden, S., Safdar, N., McLaren, D. S., Tresoldi, A. S., Lithgow, K., Urwyler, S., Varsani, C., Akbar, S., McLoughlin, K., Adeniji, K., Kearney, T., Drake, W. M., Sathyapalan, T., Higham, C. E., Karavitaki, N., Lynch, J., & Murray, R. D. (2026). Distribution, severity, and management of joint pain in patients with acromegaly. European Journal of Endocrinology, 194(3), 413-421. https://doi.org/10.1093/ejendo/lvag045

Vancouver

Kyriakakis N, Heague M, Hebden S, Safdar N, McLaren DS, Tresoldi AS, et al. Distribution, severity, and management of joint pain in patients with acromegaly. European Journal of Endocrinology. 2026;194(3):413-421. doi:10.1093/ejendo/lvag045

BibTeX
@article{Kyriakakis2026,
  author = {Kyriakakis, Nikolaos and Heague, Megan and Hebden, Sophie and Safdar, Nawaz and McLaren, David S and Tresoldi, Alberto S and Lithgow, Kirstie and Urwyler, Sandrine and Varsani, Chetna and Akbar, Shahzad and McLoughlin, Katie and Adeniji, Katarzyna and Kearney, Tara and Drake, William M and Sathyapalan, Thozhukat and Higham, Claire E and Karavitaki, Niki and Lynch, Julie and Murray, Robert D},
  title = {Distribution, severity, and management of joint pain in patients with acromegaly},
  journal = {European Journal of Endocrinology},
  year = {2026},
  volume = {194},
  number = {3},
  pages = {413--421},
  doi = {10.1093/ejendo/lvag045}
}
Kostenlos starten →